Ultrasonic topic: "제약 산업에서의 초음파 처리"

Power 초음파는 백신, 나노 제형 약물 및 약물 전달체(예: 리포좀) 생산을 위한 매우 효율적이고 신뢰할 수 있는 도구입니다. Hielscher 초음파’ 실험실, 파일럿 및 산업 시스템은 제약 등급의 미크론 및 나노 에멀젼/분산액, 리포솜 및 백신을 생산합니다. Hielscher의 초음파 시스템에는 CIP (clean-in-place) 및 SIP (sterilize-in-place)가 장착되어있어 제약 표준에 따라 안전하고 효율적인 생산을 보장합니다. 모든 특정 초음파 공정은 실험실 또는 벤치 탑 스케일에서 쉽게 테스트 할 수 있으며 산업 생산으로 선형적으로 확장 할 수 있습니다.

UIP2000hdT - 강렬한 처리를위한 화학 배치 반응기가있는 2000W 고성능 초음파기.

Found 63 hits. Showing results 1 - 12.

고강도 초음파는 GLP-1 전달을 위해 리포솜에 세마글루타이드의 재현 가능한 나노 크기와 확장 가능한 캡슐화를 가능하게 합니다.

리포좀 세마글루타이드는 GLP-1 약물 전달의 다음 큰 도약이 될 수 있습니다.

13. 2026년 2월, 캐서린 힐셔

Semaglutide and other GLP-1 peptides are among the most important modern therapeutics, but formulation scientists still face a fundamental barrier: peptide drugs are difficult to protect and deliver, especially by the oral route. Even approved oral semaglutide products show bioavailability below 1%, requiring high doses and complex formulation strategies.
A growing technical focus in pharmaceutical development is liposomal encapsulation combined with high-intensity ultrasonic processing. Liposomes can stabilize GLP-1 peptides and enable nano-scale carrier systems, while ultrasound provides reproducible nano-sizing and a scalable manufacturing pathway. Semaglutide is particularly compatible with lipid carriers because studies indicate it can associate with vesicle membranes via its lipid tail, supporting efficient loading into lipid bilayers.

https://www.hielscher.com/liposomal-semaglutide-could-be-the-next-big-leap-in-glp-1-drug-delivery.htm

Sonicator UP200St for the synthesis of biogenic medicines

Drug Manufacturing: Sonication Is Shaping the Future of Biogenic Medicines

9. January 2026, 캐서린 힐셔

This news article presents how sonication is transforming biogenic drug manufacturing: Ultrasonic processing is rapidly emerging as a key technology in the manufacturing of biogenic drugs, enabling greener, more efficient production of bioactive compounds and nanomedicines. New research demonstrates that ultrasound-assisted synthesis, using plant extracts such as broccoli, can produce highly stable, biologically active gold nanoparticles with antioxidant, wound-healing, and selective anticancer properties. High-performance probe-type sonicators, including industrial systems from Hielscher Ultrasonics, play a critical role by enhancing extraction efficiency, accelerating green nanoparticle synthesis, and ensuring precise process control. As demand grows for sustainable pharmaceutical manufacturing, sonication is positioning itself as a scalable, GMP-compatible platform for next-generation biogenic drugs.

https://www.hielscher.com/sonication-shapes-biogenic-medicines.htm